Literature DB >> 31781948

Considerations about heart rate variability in leukemia.

Vitor E Valenti1, Jociele M Kirizawa2, David M Garner2,3, Claudia Arab4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31781948     DOI： 10.1007/s00520-019-05197-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  4 in total

1.  Letter to the Editor: Re: "Is heart rate variability a valuable method to investigate cardiac autonomic dysfunction in subjects with leukemia? A systematic review to evaluate its importance in clinical practice" by Kirizawa et al.

Authors:  Maxime Caru; Daniel Curnier
Journal:  Support Care Cancer       Date:  2019-10-29       Impact factor: 3.603

2.  Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors.

Authors:  Maxime Caru; Denis Corbin; Delphine Périé; Valérie Lemay; Jacques Delfrate; Simon Drouin; Laurence Bertout; Maja Krajinovic; Caroline Laverdière; Gregor Andelfinger; Daniel Sinnett; Daniel Curnier
Journal:  Clin Res Cardiol       Date:  2019-02-18       Impact factor: 5.460

Review 3.  Heart rate variability measure in breast cancer patients and survivors: A systematic review.

Authors:  Claudia Arab; Daniel Penteado Martins Dias; Renata Thaís de Almeida Barbosa; Tatiana Dias de Carvalho; Vitor Engrácia Valenti; Tânia Brusque Crocetta; Marcelo Ferreira; Luiz Carlos de Abreu; Celso Ferreira
Journal:  Psychoneuroendocrinology       Date:  2016-02-26       Impact factor: 4.905

4.  Is heart rate variability a valuable method to investigate cardiac autonomic dysfunction in subjects with leukemia? A systematic review to evaluate its importance in clinical practice.

Authors:  Jociele M Kirizawa; David M Garner; Claudia Arab; Vitor E Valenti
Journal:  Support Care Cancer       Date:  2019-08-23       Impact factor: 3.603
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.